34% jump in Novo Nordisk profits but 2011 outlook lowered
This article was originally published in Scrip
Executive Summary
Novo Nordisk reported a 34% jump in net profit to DKK14.4 billion ($2.65 billion) for 2010, "a very good year" for the firm "with strong organic sales growth driven by the modern insulins and Victoza", said president and CEO Lars Rebien Sørensen.